Best Biopharma Outsourcing Companies in London, United Kingdom
The 102 best Biopharma Outsourcing companies in London, United Kingdom in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Ascend.
Our analysis of 100 Biopharma Outsourcing companies
$10.3b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Biopharma Outsourcing companies in London
| # | Company | Disclosed funding | Last round | Employees | Founded | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Ascend Provider of drug research & development and clinical trial services for cell & gene therapeutic services | $132M | 39 mo ago | 92 | 2021 | — | — | — | — |
| 2 | hVIVO Provider of clinical development, laboratory, and human challenge trial services | $31M | 93 mo ago | 133 | 1998 | John Oxford Founder | WordPressApple iCloud MailMySQL+25 | 18 patents Therapeutic compounds targeting cytokine storm and severe influenza, e.g., MAPK inhibitors | — |
| 3 | Letoon Holding Biotech company producing medicinal oil | $25M | 31 mo ago | — | 2023 | Giuseppe Perla Co-Founder | — | — | — |
| 4 | Lindus Health Provider of contract based clinical trial & recruitment services | $23M | 16 mo ago | 7 | 2021 | Michael Young Co-Founder & Co-CEO | WebflowApple iCloud MailGoogle Workspace+28 | — | — |
| 5 | Open Orphan Provider of testing vaccines & antivirals and CRO pharmaceutical services | $22M | 73 mo ago | 218 218 → 235 (+8%) | 2017 | — | — | — | 1 award |
| 6 | Mytos Provider of automated cell manufacturing for regenerative medicine applications | $19M | 33 mo ago | 19 | 2016 | Ignacio Willats Co-Founder | WebflowYouTubeHubSpot+11 | — | — |
| 7 | Thiakis Limited information available | $18M | 240 mo ago | 3 | 2004 | Bernard Poussot CEO | — | — | — |
| 8 | Prescient Healthcare Group Consulting services for product strategy and decision support | $13M | 24 mo ago | 217 | 2007 | Jamie Denison Pender CEO | WordPressApple iCloud MailMicrosoft 365+31 | — | 1 launch · 1 award |
| 9 | Nexus BioQuest Provider of drug discovery services | $5M | 46 mo ago | 16 | 2022 | — | WordPress Block EditorWordPressMySQL+20 | — | 1 job opening |
| 10 | Life Science People Provider of drug discovery, regulatory, marketing, staffing, and other services for biopharma sector | $5M | 34 mo ago | 17 | 2020 | — | — | — | — |
| 11 | SPARTA Biodiscovery Enabling nanoformulations for next-generation therapeutics through cutting-edge benchtop technology. | $4M | 32 mo ago | — | 2022 | Jelle Penders Chief Executive Officer | WordPressPleskMySQL+26 | — | 1 launch |
| 12 | Perceptive Provider of preclinical imaging services | $3M | 189 mo ago | — | 2000 | David Herron Chief Executive Officer | WordPressZohoMySQL+27 | — | — |
| 13 | ConcR Provider of a platform predicting therapeutic response and outcome for cancer | $3M | 33 mo ago | 6 | 2018 | Matt Foster CEO | Craft CMSPHPYii+11 | — | 1 partnership |
| 14 | IASO Pharma Biopharmaceutical company specializing in advanced cell therapies | $3M | 181 mo ago | 2 | 2007 | — | — | — | — |
| 15 | Clerkenwell Health CRO focused on conducting early stage clinical development of psychedelic medicines | $2M | 44 mo ago | 28 | 2020 | — | Cart FunctionalitySquarespace CommerceSquarespace+17 | — | 4 job openings |
| 16 | GT LifeScience Provider of data science and engineering services to life sciences companies | $2M | 32 mo ago | — | 2020 | Andy Baynes Co-Founder & CEO | — | — | — |
| 17 | Verisian Developer of clinical trial analysis solutions using traceability and AI | $1M | 33 mo ago | — | 2023 | Henning Kuich Co-Founder and CTO | WebflowHubSpotcore-js+14 | — | — |
| 18 | PBR Life Sciences Provider of market research consulting services for life science sector | $1M | 18 mo ago | — | 2015 | Oluyinka Yinka Co-Founder | WordPressMySQLZoho+24 | — | — |
| 19 | Imanova Company offering services for drug development through their expertise in PET and MRI imaging and… | $306K | 120 mo ago | 90 | 2011 | — | — | — | — |
| 20 | Transpharmation Provider of preclinical neuroscience contract research services using animal models. | $306K | 77 mo ago | 87 | 2002 | Joseph Araujo Co-Founder & Director | Apple iCloud MailMicrosoft 365Algolia+10 | — | — |
| 21 | Pharmidex Company specializing in providing translational research services | $111K | 113 mo ago | — | 2002 | Mohammad Alavijeh CEO & MD | DudaSnowplow AnalyticsGoogle Analytics+18 | — | 1 internship · 1 partnership |
| 22 | Kapsule Provider of the healthcare market and business intelligence platform | $100K | 45 mo ago | 2 | 2018 | Hannan Hashmi Co-Founder & Co-CEO | Node.jsTailwind CSSReact+13 | — | — |
Top 12 Biopharma Outsourcing companies in London
#1
Series B · London, England · founded 2021 · 7 employees$23Mraised▾
Provider of contract based clinical trial & recruitment services
- Jan 2025Series B$55M
- Aug 2023Series A$18M
- Jun 2023Seed—
- May 2023Grant (prize money)$543.1K
#2
Seed · London, England · founded 2015$1.1Mraised▾
Provider of market research consulting services for life science sector. It connects businesses with real-world opportunities in life sciences by combining data, technology, and people. It offers research data visualization platforms and research support apps that combine data curated quarterly from healthcare professionals and patients.
- Dec 2024Seed$1M
- Dec 2023Seed$120K
#3
Series B · London, England · founded 2007 · 217 employees$12.7Mraised▾
Prescient Healthcare Group offers consulting services throughout the life product life cycle for clinical and medical strategic market access, commercial planning, stakeholder insights, competitive insights, market analytics & forecasting.
- Jun 2024Series B$18.3K
- Jul 2023Series B$50.1K
- Jan 2021Series B$12.6M
- Jul 2017Series A—
#4
Series A · London, England · founded 2021 · 92 employees$132.5Mraised▾
Provider of drug research & development and clinical trial services for cell & gene therapeutic services
- Mar 2023Series A$66.6M
#5
Series B · London, England · founded 2023$24.6Mraised▾
Biotech company producing medicinal oil. The company produces medicinal oil and active ingredients derived from plant matrices.
- Nov 2023Series B$24.6M
#6
Series A · London, England · founded 2016 · 19 employees$19Mraised▾
Provider of automated cell manufacturing for regenerative medicine applications. It offers technology that automates cell culture unit operations. The company’s technology enables consistent production at a low cost per dose. It handles manufacturing, from process and analytical development to regulatory support. The company's technology reduces labor and cleanroom footprint.
- Sep 2023Series A$19M
#7
Series A · London, England · founded 2022$4.3Mraised▾
SPARTA Biodiscovery is a company that specializes in enabling nanoformulations for next-generation therapeutics. They offer a cutting-edge benchtop instrument called SPARTA® (Single Particle Automated Raman Trapping Analysis) and provide analytical services using their patented technology.
- Oct 2023Series A$4.3M
#8
Seed · London, England · founded 2018 · 6 employees$3.1Mraised▾
Provider of a platform predicting therapeutic response and outcome for cancer. The platform uses advanced modeling and predictions for science and clinical research. It translates disparate oncology datasets to uncover best indications with minimal data. The platform selects responders with patient-specific biomarkers and de-risks trials via in-silico simulations and digital controls.
- Sep 2023Seed$879.8K
- Mar 2023Seed$1.2M
- Nov 2021Seed$667.9K
- Mar 2021Seed$336.8K
#9
Series A · London, England · founded 2020 · 17 employees$5.1Mraised▾
Provider of drug discovery, regulatory, marketing, staffing, and other services for biopharma sector
- Aug 2023Series A$5.1M
#10
Funding Raised · London, England · founded 2020$2.2Mraised▾
Provider of data science and engineering services to life sciences companies. It offers end-to-end product development, including AI/ML integration, data management and visualization, front-end and back-end development, and quality management. Services also encompass product management, medical services desk support, and security advisory. The company builds dedicated teams to integrate directly with client operations, providing support ranging from initial prototyping to full-scale production and maintenance. This includes assistance with data infrastructure development, improving data processing and analysis, and streamlining workflows to enhance efficiency and regulatory compliance.
- Sep 2023Grant (prize money)$1.6M
- Sep 2023Grant (prize money)$348.9K
- Aug 2023Grant (prize money)$155.7K
#11
Seed · London, England · founded 2022 · 16 employees$5.2Mraised▾
Provider of drug discovery services
- Jul 2022Seed$4.4M
- Jul 2022Seed$643K
- Jul 2022Seed$178K
#12
Seed · London, England · founded 2023$1.3Mraised▾
Developer of clinical trial analysis solutions using traceability and AI. The company provides tools for validation, data exploration, and issue tracking in clinical studies. These products aim to improve the speed and quality of analyses, submissions, and regulatory reviews. The company's solutions support pharmaceutical companies, biotechs, CROs, and regulatory agencies.
- Sep 2023Seed$1.3M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Biopharma Outsourcing coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology in London is moving
A read on the academic research around Biotechnology in London — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 246 papers.
London's Imperial College, UCL, and King's College drive predominantly optimistic biotechnology research—centered on RNA splicing, CRISPR, and malaria control—with breakthroughs outpacing concerns nearly 2:1.
- Imperial College London70
- University College London67
- King\'s College London41
- London School of Hygiene & Tropical Medicine28
- Queen Mary University of London22
- Chromatin1→4
- Antibody1→4
- Messenger RNA1→3
- Antibiotic resistance1→3
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.